286 related articles for article (PubMed ID: 29760130)
1. Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.
Coolen-Allou N; Touron T; Belmonte O; Gazaille V; Andre M; Allyn J; Picot S; Payet A; Veziris N
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760130
[No Abstract] [Full Text] [Related]
2. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
Chu HS; Chang SC; Shen EP; Hu FR
PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
[TBL] [Abstract][Full Text] [Related]
3. First report of lung transplantation in a patient with active pulmonary Mycobacterium simiae infection.
Qvist T; Katzenstein TL; Lillebaek T; Iversen M; Mared L; Andersen AB
Transplant Proc; 2013 Mar; 45(2):803-5. PubMed ID: 23267789
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
Hershko Y; Adler A
Microb Drug Resist; 2023 Jul; 29(7):302-308. PubMed ID: 37219996
[TBL] [Abstract][Full Text] [Related]
5. Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
Daneshfar S; Khosravi AD; Hashemzadeh M
PLoS One; 2022; 17(8):e0267320. PubMed ID: 35960778
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
[TBL] [Abstract][Full Text] [Related]
8. [Infections due to Mycobacterium simiae].
García-Martos P; García-Agudo L; González-Moya E; Galán F; Rodríguez-Iglesias M
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):e37-43. PubMed ID: 25444043
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary disease caused by Mycobacterium simiae in Iran's national referral center for tuberculosis.
Baghaei P; Tabarsi P; Farnia P; Marjani M; Sheikholeslami FM; Chitsaz M; Gorji Bayani P; Shamaei M; Mansouri D; Masjedi MR; Velayati AA
J Infect Dev Ctries; 2012 Jan; 6(1):23-8. PubMed ID: 22240424
[TBL] [Abstract][Full Text] [Related]
10. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].
Ceyhan İ; Özkara Ş; Güler MZ; Dulkar G; Altınsoy R; Vezir S
Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634
[TBL] [Abstract][Full Text] [Related]
11. Non-tuberculous mycobacteria profiles and their anti-mycobacterial resistance at a major medical center in Lebanon.
Araj GF; Baba OZ; Itani LY; Avedissian AZ; Sobh GM
J Infect Dev Ctries; 2019 Jul; 13(7):612-618. PubMed ID: 32065818
[TBL] [Abstract][Full Text] [Related]
12. The antimicrobial susceptibility of non-tuberculous mycobacteria.
Cowman S; Burns K; Benson S; Wilson R; Loebinger MR
J Infect; 2016 Mar; 72(3):324-31. PubMed ID: 26723913
[TBL] [Abstract][Full Text] [Related]
13. Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
Park J; Cho J; Lee CH; Han SK; Yim JJ
Clin Infect Dis; 2017 Feb; 64(3):301-308. PubMed ID: 28011609
[TBL] [Abstract][Full Text] [Related]
14. Investigation of drug regimens and treatment outcome in patients with
Dashtbin S; Mirkalantari S; Dadashi M; Darban-Sarokhalil D
Expert Rev Anti Infect Ther; 2022 Jul; 20(7):1015-1023. PubMed ID: 35306950
[TBL] [Abstract][Full Text] [Related]
15. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
Gitti Z; Mantadakis E; Maraki S; Samonis G
Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
[TBL] [Abstract][Full Text] [Related]
18. Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study.
Campos-Herrero MI; Chamizo FJ; Caminero JA; Gilarranz R; Cabrera G; Cuyás J
J Infect Chemother; 2016 Aug; 22(8):526-31. PubMed ID: 27262751
[TBL] [Abstract][Full Text] [Related]
19. The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.
Khan O; Chaudary N
Drug Des Devel Ther; 2020; 14():2287-2294. PubMed ID: 32606598
[TBL] [Abstract][Full Text] [Related]
20. Treatment of slowly growing mycobacteria.
Philley JV; Griffith DE
Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
